Michael S. Weiss

2018 - TG Therapeutics

In 2018, Michael S. Weiss earned a total compensation of $14.3M as Chief Executive Officer and President at TG Therapeutics, a 44% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$154,500
Salary$655,625
Stock Awards$13,488,646
Total$14,298,771

Weiss received $13.5M in stock awards, accounting for 94% of the total pay in 2018.

Weiss also received $154.5K in non-equity incentive plan and $655.6K in salary.

Rankings

In 2018, Michael S. Weiss' compensation ranked 345th out of 14,244 executives tracked by ExecPay. In other words, Weiss earned more than 97.6% of executives.

ClassificationRankingPercentile
All
345
out of 14,244
98th
Division
Manufacturing
117
out of 5,758
98th
Major group
Chemicals And Allied Products
36
out of 2,119
98th
Industry group
Drugs
29
out of 1,808
98th
Industry
Pharmaceutical Preparations
21
out of 1,382
99th

Pay ratio

Michael S. Weiss' Pay$14,298,771
Median Employee's Pay$113,181
Pay Ratio

126

to 1

In 2018, the annual total compensation of Michael S. Weiss was $14,298,771.

The annual total compensation of the median employee at TG Therapeutics was $113,181.

The ratio of Michael S. Weiss' pay to the pay of median employee was therefore 126 to one.

Source: SEC filing on April 30, 2019.

Weiss' colleagues

We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2018.

2018

Sean Power

TG Therapeutics

Chief Financial Officer

News

You may also like